Scarica l'app Stockscreener
31.23
1.67%
-0.53
Dopo l'orario di chiusura:
30.78
-0.45
-1.44%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$31.76
Aprire:
$31.05
Volume 24 ore:
530.57K
Relative Volume:
1.19
Capitalizzazione di mercato:
$1.15B
Reddito:
$154.15M
Utile/perdita netta:
$-33.58M
Rapporto P/E:
-32.53
EPS:
-0.96
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
-13.71%
1M Prestazione:
+1.49%
6M Prestazione:
+1.66%
1 anno Prestazione:
+27.21%
Intervallo 1D:
$30.12
$31.67
Intervallo di 1 settimana:
$30.12
$36.60
Portata 52W:
$20.85
$59.23
Harrow Inc Stock (HROW) Company Profile
Nome
Harrow Inc
Settore
Telefono
615.733.4731
Indirizzo
1A BURTON HILLS BLVD, NASHVILLE, CA
Confronta HROW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
31.23 | 1.17B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Iniziato | BTIG Research | Buy |
| 2025-06-10 | Iniziato | William Blair | Outperform |
| 2025-02-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-04 | Reiterato | B. Riley Securities | Buy |
| 2024-04-11 | Iniziato | Craig Hallum | Buy |
| 2022-09-08 | Ripresa | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-09-24 | Iniziato | Aegis Capital | Buy |
| 2021-07-02 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Harrow Inc Borsa (HROW) Ultime notizie
What markets is Harrow Inc. expanding into Is Zedge Inc. stock a good long term investment optionAdvanced Screener Growth Plan For Every Investor - jammulinksnews.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW - GlobeNewswire Inc.
When is Harrow Inc. stock expected to show significant growthReal Time Tracker For Fast Growth - jammulinksnews.com
Is Harrow Inc. stock overvalued or undervaluedBeginner Investor Ideas For Smart Trading - jammulinksnews.com
What are Harrow Inc. company’s key revenue driversMarket Forecast Recommendation With Low Risk - jammulinksnews.com
What are the technical indicators suggesting about Harrow Inc.AI Powered Strategy For 2025 - jammulinksnews.com
What Fibonacci levels say about Harrow Inc. reboundTrade Timing Strategy With Technical Data Explained - metal.it
Candlestick Reversal Detected on Harrow Inc.’s ChartSwing Setup With Technical Confirmation Explained - metal.it
What is the risk reward ratio of investing in Harrow Inc. stockFree Stock Target Finder That Work - jammulinksnews.com
Institutional owners may ignore Harrow, Inc.'s (NASDAQ:HROW) recent US$81m market cap decline as longer-term profits stay in the green - simplywall.st
Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 - GlobeNewswire
Leading Eyecare Pharma Harrow Sets Q2 Earnings Release: Key Details for Investors - Stock Titan
Why Harrow Inc. stock attracts strong analyst attentionDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
Real time social sentiment graph for Harrow Inc.Swing Trade Entry With Volume Triggers Released - metal.it
Published on: 2025-07-28 19:53:29 - metal.it
How volatile is Harrow Inc. stock compared to the marketWealth Building Watchlist For Every Investor - jammulinksnews.com
How does Harrow Inc. generate profit in a changing economyInvest confidently with daily market forecasts - jammulinksnews.com
What is the dividend policy of Harrow Inc. stockAchieve consistent double-digit returns - jammulinksnews.com
Why Harrow Inc. stock is on top investor watchlistsCarefully Curated High Return Stocks - beatles.ru
What are analysts’ price targets for Harrow Inc. in the next 12 monthsStrong return on assets - jammulinksnews.com
What catalysts could drive Harrow Inc. stock higher in 2025Dynamic investment opportunities - jammulinksnews.com
What makes Harrow Inc. stock price move sharplyControlled Risk High Reward Plan - metal.it
Is it the right time to buy Harrow Inc. stockUnlock expert stock analysis and alerts - jammulinksnews.com
What are the latest earnings results for Harrow Inc.Fastest-growing stock picks - jammulinksnews.com
Does Harrow Inc. stock perform well during market downturnsGet timely alerts on market movers - jammulinksnews.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc.HROW - WV News
Harrow, Inc. (HROW): A Bull Case Theory - MSN
Harrow Inc. Stock Analysis and ForecastExplosive wealth accumulation - PrintWeekIndia
What drives Harrow Inc. stock priceFree Technical Analysis Support - PrintWeekIndia
What analysts say about Harrow Inc. stockFree Stock Market Trend Analysis - Autocar Professional
Is Harrow Inc. a good long term investmentRapid capital growth - jammulinksnews.com
Harrow Inc Azioni (HROW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Harrow Inc Azioni (HROW) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Sale |
30.80 |
15,000 |
462,033 |
90,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 09 '25 |
Sale |
30.37 |
15,204 |
461,794 |
105,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 03 '25 |
Sale |
30.04 |
3,000 |
90,116 |
122,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 04 '25 |
Sale |
30.02 |
1,796 |
53,907 |
120,204 |
| Opaleye Management Inc. | 10% Owner |
May 12 '25 |
Sale |
25.90 |
10,000 |
258,959 |
130,000 |
| Opaleye Management Inc. | 10% Owner |
May 13 '25 |
Sale |
26.59 |
5,000 |
132,945 |
125,000 |
| BOLL ANDREW R. | Chief Financial Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
346,500 |
0 |
914,589 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx |
Apr 03 '25 |
Option Exercise |
0.00 |
277,200 |
0 |
576,863 |
| BAUM MARK L | Chief Executive Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
762,300 |
0 |
2,899,825 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '25 |
Sale |
30.01 |
5,000 |
150,055 |
140,000 |
0.87%
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):